Molecule Details
| InChIKey | FIDLLEYNNRGVFR-CTNGQTDRSA-N |
|---|---|
| Canonical SMILES | O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.78 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB15675 |
|---|---|
| Drug Name | Baloxavir |
| CAS Number | 1985605-59-1 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Baloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and Oseltamavir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)). |
Categories: Anti-Infective Agents Antiviral Agents Baloxavir and prodrugs Chelating Activity Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Oxazines Polymerase Acidic Endonuclease Inhibitors Pyridines Sulfur Compounds Thiepins
Cross-references: ChemSpider: 64854031 PDB: E4Z RxCUI: 2197842 Wikipedia: Baloxavir_marboxil